Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Phase 1b norovirus challenge study is underway at Emory University School of MedicineCDI-988 is the first oral antiviral ...
MobiHealthNews

Insilico Medicine signs $2.75B AI drug discovery deal with Eli Lilly

The deal grants Lilly exclusive global rights to use Insilico's Pharma.AI platform for drug discovery and development across ...
Crypto Briefing

Roche deploys 3,500 Nvidia Blackwell GPUs to supercharge drug discovery

Roche now operates over 3,500 Nvidia Blackwell GPUs for AI-driven drug discovery, making it the pharma industry's largest ...
Morningstar

Frontage Laboratories Expands Early Phase Clinical Capabilities to Support Global Drug Development

EXTON, Pa., Jan. 30, 2026 /PRNewswire/ -- Frontage Laboratories, Inc. ("Frontage"), a global Contract Research, Development and Manufacturing Organization (CRDMO), today announced the expansion of its ...
YourStory

A technologist’s journey into shortening drug discovery, shaped by OpenAI tools

Drug discovery has long been defined by time, cost, and repeated failure. Medvolt AI is using OpenAI-enabled intelligence to ...
BioTechniques

Wins and warnings: AI in cancer drug discovery and development

Bissan Al-Lazikani (left) is a Professor of Genomic Medicine and Director of Therapeutics Data Science at The University of Texas MD Anderson Cancer Center (Houston, TX, USA), where she heads an ...
GEN

StockWatch: Abivax Shares Leap on Phase III Ulcerative Colitis Data, $747.5M Offering

A day after surpassing its own expectations with dazzling Phase III data for its lead pipeline candidate, the oral ulcerative colitis (UC) drug obefazimod, Abivax (Euronext Paris and NASDAQ: ABVX) so ...